Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)
Condition(s):Colorectal Cancer; Chemotherapy-induced Peripheral NeuropathyLast Updated:December 17, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):Colorectal Cancer; Chemotherapy-induced Peripheral NeuropathyLast Updated:December 17, 2021Terminated
Condition(s):Advanced Metastatic (Stage IV) Colorectal CancerLast Updated:July 6, 2018Completed
Condition(s):Impulsive BehaviorLast Updated:April 19, 2021Unknown status
Condition(s):Optic Disc Edema; Endothelial DysfunctionLast Updated:November 8, 2023Recruiting
Condition(s):Diabetic Peripheral NeuropathyLast Updated:January 11, 2012Unknown status
Condition(s):Hyperhomocysteinemia; HyperlipoproteinemiasLast Updated:December 15, 2023Completed
Condition(s):Sleep Quality; Sleep HealthLast Updated:July 12, 2022Completed
Condition(s):SleepLast Updated:May 22, 2018Completed
Condition(s):Chronic PainLast Updated:February 8, 2024Recruiting
Condition(s):Cancer; Myocardial Infarction; Cerebrovascular StrokeLast Updated:November 5, 2015Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.